Menu

1 / 20

U.S. demand for menopause hormone therapy has more than doubled recently

#sciencenews#science#health#women#menopause
Long article (486 words) — no AI summary yet.
Reading 0:00
15s threshold

More U.S. women are taking menopause hormone therapy, new prescription data suggest.

Monthly dispensing of hormone therapy for women aged 40 to 74 more than doubled since 2023, growing from 2 million to 4.9 million, researchers report November 19 in JAMA . The analysis of U.S. pharmacy dispensing data revealed that this increase began in 2024. The rise continued in 2025, before and after the Food and Drug Administration’s November removal of the black box warning from packaging, and into 2026.

Although the data in the new study are aggregate, the researchers used population data to estimate the dispensing rate for this age group, which jumped from 28 prescriptions per 1,000 women to 67 prescriptions per 1,000 over the period studied.

The new study wasn’t designed to determine what’s behind the increase. It’s possible that the evidence regarding hormone therapy’s safety and effectiveness for the treatment of menopause symptoms, such as hot flashes, is reaching more women.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.